More reports of eye infections caused by fungal endophthalmitis in patients who were treated with Brilliant Blue G (BBG) during eye surgery have prompted the Food and Drug Administration (FDA) to issue a second warning in a month’s time about the drug. The agency is warning that eye infections were also reported in patients who were given injections of drug products containing triamcinolone during eye surgery. BBG is a stain used to assist surgeons in retinal surgery. A recall of BBG was issued last month. It is not approved for use in the United States, and health care personnel are ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.